{
  "trial_id": "NCT00241839",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "African American",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Untreated with antihypertensive agent",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "BP between 140/90 and 159/99 mm Hg",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Random spot urine protein/creatinine ratio of less than 0.5",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Calculated MDRD GFR of greater than or equal to 60 ml/min/1.73/m^2",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "No allopurinol or probenecid intake for at least one month prior to study entry",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Willing and able to cooperate with study procedures",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Willing to travel to the GCRC at Shands Hospital for overnight inpatient stays on two separate occasions",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "History of malignant or accelerated hypertension",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Confirmed total white cell count of less than 2,500/mm^3",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Known history of liver disease",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Known secondary cause of hypertension",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "52",
    "trial_id": "NCT00241839",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}